BD Announces Results For 2020 First Fiscal Quarter; Lowers Fiscal 2020 Guidance
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: PR Newswire
FRANKLIN LAKES, N.J., Feb. 6, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.225 billion for the first fiscal quarter ended December 31, 2019. This represents an increase of 1.6 percent as reported over the prior-year period, or 2.5 percent on a currency-neutral basis.BD also announced today that it is continuing to work with the U.S. Federal Drug Administration (FDA) on its software remediation plan for the Alaris System, which will require additional regulatory filings beyond what the company previously anticipated. The company expects to submit its comprehensive regulatory filing in the fourth quarter of fiscal year 2020. In the interim, the company will partner with the FDA and existing customers to ensure continued access to the Alaris System under medical necessity. As a result, the company is lowering its full fiscal year revenue and adjusted diluted earnings per share gu
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- Closed System Transfer Devices Market Size Expected to Reach USD 5.39 Bn by 2033 | Expansion of Oncology and Infusion Services [Yahoo! Finance]Yahoo! Finance
- Levi & Korsinsky, LLP Notifies Shareholders of Becton, Dickinson and Company (BDX) an Upcoming Claims Deadline in a Class Action SettlementAccesswire
- Outcome Capital Continues to Expand with the Addition of Industry Veteran Stanislav Glezer, MD MBA [Yahoo! Finance]Yahoo! Finance
- Becton, Dickinson and Company (NYSE: BDX) had its price target raised by analysts at Barclays PLC from $305.00 to $312.00. They now have an "overweight" rating on the stock.MarketBeat
- Injectable Drug Delivery Market Worth $1139.4 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 5/2/24 - Beat
BDX
Sec Filings
- 5/6/24 - Form 4
- 5/6/24 - Form 4
- 5/2/24 - Form S-3ASR
- BDX's page on the SEC website